Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Trinity Biotech plc TRIB is 20.40%. Trinity Biotech's revenue for the same period is $82.97 million.
The trailing-twelve-month profit margin at Meridian Bioscience VIVO is 20.35%. Meridian Bioscience's ROE for the same period is 25.63%.
The trailing-twelve-month profit margin at Abaxis ABAX is 14.87%. Abaxis's PEG ratio is 2.96.
The trailing-twelve-month profit margin at IDEXX Laboratories IDXX is 14.02%. IDEXX Laboratories had $251.01 million in total cash for the latest quarter.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in